Teva says efforts to resolve DOJ generic drug price-fixing probe are 'ongoing'
MLex Summary: Teva Pharmaceuticals said in a securities filing that it is continuing its efforts to resolve a long-running criminal price-fixing investigation by the US Department of Justice over generic drugs....To view the full article, register now.
Already a subscriber? Click here to view full article